MBA Students’ visit from San Francisco University

2016.10.12

This autumn József Répási have met with MBA students from University of San Francisco. During the meeting Mr. Répási talked about the new stragegy of the company and his opinion about the appropriate attitude of everyday work to meet the challenges and reach our goals. The meeting was closed with a guided site tour and […]

Read more...

Interview Jozsef Repasi – Managing Director, Soneas, Hungary

2016.06.08

Soneas MD Jozsef Repasi discusses the shift back towards Central and Eastern Europe for contract manufacturing services, the company’s growth since separating from Ubichem, and his ambitions for Soneas to become a fully integrated, end-to-end service provider.   http://pharmaboardroom.com/interviews/interview-jozsef-repasi-managing-director-soneas-hungary/  

Read more...

MBA students’ visit from Montclair State University

2016.05.24

MBA students from Montclair State University (Montclair, NJ, USA) have visited Soneas Research Ltd (Budapest, Hungary) at its Berlini site in 05-23-2016. During the event the Founder and Managing Direct of Soneas Research Ltd (formally Ubichem Research Ltd) József Répásai, held a lecture about the history of the company, its present and future opportunities and […]

Read more...

ChemSpec Europe in Basel, Switzerland – June 1-2, 2016

2016.05.03

Chemspec Europe 2016 is the international exhibition for fine and speciality chemicals. For purchasers and agents looking for specific products or bespoke solutions, the event is the ideal marketplace to meet with manufacturers, suppliers and distributors of fine and speciality chemicals. With its dedicated exhibition profile Chemspec Europe is the place to be for international […]

Read more...

Partner Collaborations Advance Second-Generation Elevance Biorefinery Technology

Woodridge, Illinois, USA (Jan. 19, 2016) – In collaboration with several partners, including the special contribution of Versalis under a strategic partnership started in early 2014, Elevance Renewable Sciences, Inc. — a high-growth company that creates novel specialty chemicals from natural oils — has successfully completed scale-up of a second-generation biorefinery technology of the company’s […]

Read more...

Information about company name change

2015.10.07

We would like to hereby inform you that the corporate name of Ubichem Research Ltd. has changed to SONEAS research Ltd. (in Hungarian: SONEAS Kutató Kft.)   About the name change (pdf)   We would like to hereby inform you that the corporate name of Ubichem Pharma Manufacturing Ltd. has changed to SONEAS Chemicals Ltd. […]

Read more...

UBICHEM Pharma Group inks deal to produce XiMo’s metathesis catalysts

2014.06.01

UBICHEM Pharma Group has entered into a strategic partnership with Swiss-based XiMo AG, a company focusing on the development and application of proprietary metathesis catalysts, for use in the specialty chemical, agro chemical, renewables, pharmaceutical, flavors and fragrances, polymers and advanced materials sectors. “Our molybdenum and tungsten catalysts are based on the breakthrough scientific research […]

Read more...

UBICHEM Pharma Group adds new large scale manufacturing site

2012.06.12

Today UBICHEM Pharma Group announced further growth of its business by adding a new manufacturing site. The new member of the group, UBICHEM Pharma Manufacturing, will be producing starting materials, intermediates and other fine chemical products for pharma and non-pharma applications in industrial quantities. This expansion positions the UBICHEM Pharma Group to be one of […]

Read more...

Small is beautiful – changing paradigm in the drug discovery

2012.03.12

 The Global Discovery to Development Innovations Forum was held in Budapest on 7-9 March 2012 in partnership with Ubichem Pharma Services. Mr. József Répási, CEO, Ubichem Pharma Services presented the new ways in drug discovery and development.

Read more...

Ubichem Research acquisition

2011.05.30

Ubichem Research acquisition to enable further growth of Pharma Services business   The majority share of Ubichem Research Ltd has been acquired by financial investment company Lochlomond Holding Limited, owned by Marton Szoke, and is now independent of Ubichem Plc in the UK. The remaining minority share of Ubichem Research remains in the ownership of Mr. […]

Read more...

Request a call!

 

Thank you for your interest in Ubichem's solutions. Please, complete and submit this form, and one of our specialists will contact you shortly.